# EXHAUSTIVE STUDY GUIDE: Cardiovascular & Diabetes Pharmacology

This guide is compiled from Dr. James's lecture materials and textbook references (Clayton 19th Ed, CMS PN 8.0).

---

## I. CARDIOVASCULAR MEDICATIONS

### 1. Antihyperlipidemics (Antilipemics)

#### A. STATINS (HMG-CoA Reductase Inhibitors)
1.  **Drug Name:** Atorvastatin (Lipitor), Simvastatin (Zocor), Lovastatin (Mevacor), Pravastatin (Pravachol), Rosuvastatin (Crestor), Fluvastatin (Lescol).
2.  **Class/Mechanism:** Inhibits HMG-CoA reductase (liver enzyme for cholesterol synthesis). Increases LDL uptake from blood; can raise HDL.
3.  **Indications:** Primary hyperlipidemia; prevention of CVD (primary and secondary).
4.  **Contraindications:** **Active liver disease**, Pregnancy.
5.  **Adverse Effects:** **Myalgia** (common), **Rhabdomyolysis** (severe muscle damage leading to renal failure - check CK levels), **Hepatotoxicity** (elevated LFTs), GI symptoms, Headache.
6.  **Drug Interactions:** **Grapefruit juice** (increases levels/toxicity), **Warfarin** (increases bleeding risk), certain antibiotics/antifungals (clarithromycin, itraconazole).
7.  **Dosage & Administration:** Oral. **Evening dosing is preferred** (cholesterol synthesis peaks at night). Baseline LFTs and lipid panel required.
8.  **Patient Education:** Report unexplained muscle pain/tenderness or tea-colored urine immediately. Avoid grapefruit juice. Regular lab monitoring required.

#### B. Cholesterol Absorption Inhibitor
1.  **Drug Name:** Ezetimibe (Zetia).
2.  **Class/Mechanism:** Acts on the small intestine to prevent cholesterol absorption.
3.  **Indications:** Primary hypercholesterolemia. Used alone or with statins.
4.  **Contraindications:** Liver disease (when used with statins).
5.  **Adverse Effects:** Abdominal pain, diarrhea, headache, fatigue, joint pain. Serious: Hepatotoxicity, myopathy (rare).
6.  **Drug Interactions:** Statins (increase liver risk), Bile acid sequestrants (reduce absorption—separate by 2-4 hrs), Fibrates (increase gallstone risk).
7.  **Dosage & Administration:** Oral, once daily.
8.  **Patient Education:** Report muscle pain if taking with statins. Follow low-cholesterol diet.

#### C. Bile Acid Resins (Sequestrants)
1.  **Drug Name:** Cholestyramine (Questran), Colesevelam (Welchol), Colestipol (Colestid).
2.  **Class/Mechanism:** Bind bile acids in the intestine, preventing reabsorption. Liver uses more cholesterol to make bile, lowering blood levels.
3.  **Indications:** Primary hyperlipidemia; used for statin intolerance.
4.  **Contraindications:** Complete biliary obstruction, Hypertriglyceridemia (>300-400 mg/dL).
5.  **Adverse Effects:** **Constipation**, bloating, nausea, flatulence. Can raise triglycerides. Vitamin deficiency (A, D, E, K).
6.  **Drug Interactions:** Binds to many meds (Warfarin, Digoxin, Thiazides, Levothyroxine). **Take other meds 1 hour before or 4-6 hours after.**
7.  **Dosage & Administration:** Powder/granules mixed with liquid (not dry).
8.  **Patient Education:** Increase fiber/fluids to prevent constipation. Timing of other meds is critical.

#### D. Fibric Acids (Fibrates)
1.  **Drug Name:** Gemfibrozil (Lopid), Fenofibrate (Tricor).
2.  **Class/Mechanism:** Induce lipid metabolism; increase triglyceride elimination.
3.  **Indications:** High triglycerides (TG); low HDL.
4.  **Contraindications:** Severe renal/hepatic disease, Gallbladder disease.
5.  **Adverse Effects:** GI distress, Hepatotoxicity, **Gallstones**, Myopathy (especially with statins).
6.  **Drug Interactions:** Statins (increase rhabdo risk), Warfarin (increase bleeding).
7.  **Dosage & Administration:** **Take 30 min before morning and evening meals.**
8.  **Patient Education:** Report RUQ pain (gallstones) or muscle pain.

#### E. Niacin (Vitamin B3)
1.  **Drug Name:** Niacin (Nicotinic Acid).
2.  **Class/Mechanism:** Limits liver production of blood fats.
3.  **Indications:** High triglycerides; mild LDL lowering.
4.  **Contraindications:** Liver disease, severe gout, active peptic ulcer.
5.  **Adverse Effects:** **Intense flushing**, itching, rash (histamine release), hypotension (vasodilator), hyperglycemia (use caution in diabetics).
6.  **Drug Interactions:** Other antihypertensives (additive hypotension).
7.  **Dosage & Administration:** Prescription dose (1-6g/d) vs supplement (20mg).
8.  **Patient Education:** **Take Aspirin/NSAID 30 min before** to reduce flushing.

---

### 2. Antihypertensives

#### A. ACE Inhibitors
1.  **Drug Name:** Captopril (Capoten), Enalapril (Vasotec), Lisinopril (Prinivil), Ramipril (Altace), Fosinopril.
2.  **Class/Mechanism:** Blocks conversion of Angiotensin I to II. Prevents vasoconstriction and aldosterone release.
3.  **Indications:** Hypertension, Heart Failure, Post-MI, diabetic nephropathy.
4.  **Contraindications:** **Pregnancy (Teratogenic)**, History of angioedema.
5.  **Adverse Effects:** **Dry cough** (bradykinin), **Angioedema** (swelling of face/airway—emergency), **Hyperkalemia**, first-dose hypotension, Altered taste/Neutropenia (Captopril).
6.  **Drug Interactions:** Potassium-sparing diuretics/supplements (Hyperkalemia), NSAIDs (reduce effect/damage kidneys), Lithium (toxicity).
7.  **Dosage & Administration:** Oral. Monitor BP, K+, and Creatinine.
8.  **Patient Education:** Report persistent cough or facial swelling. Change positions slowly. Avoid salt substitutes.

#### B. Angiotensin II Receptor Blockers (ARBs)
1.  **Drug Name:** Losartan (Cozaar), Valsartan (Diovan).
2.  **Class/Mechanism:** Blocks Angiotensin II from binding to receptors.
3.  **Indications:** Hypertension, Heart Failure (if ACE-I not tolerated), CKD.
4.  **Contraindications:** Pregnancy, Renal impairment.
5.  **Adverse Effects:** Dizziness, headache, hyperkalemia. **Low risk of cough.**
6.  **Drug Interactions:** Same as ACE-I.
7.  **Dosage & Administration:** Oral.
8.  **Patient Education:** Same as ACE-I; notify if pregnant.

#### C. Calcium Channel Blockers (CCBs)
1.  **Drug Name:** Amlodipine (Norvasc), Nifedipine (Procardia), Verapamil (Calan), Diltiazem (Cardizem).
2.  **Class/Mechanism:** Blocks calcium entry into heart/vessel muscles. Dihydropyridines (-dipines) are vasodilators; Non-dihydropyridines (Verapamil/Diltiazem) also slow HR and contractility.
3.  **Indications:** HTN, Angina, Dysrhythmias (Verapamil/Diltiazem).
4.  **Contraindications:** Heart block, severe bradycardia. Verapamil/Diltiazem contraindicated in HF.
5.  **Adverse Effects:** **Peripheral edema** (-dipines), **Constipation** (Verapamil), Bradycardia (Non-DHPs), Headache, flushing, Gingival hyperplasia.
6.  **Drug Interactions:** **Grapefruit juice** (toxicity), Beta-blockers (heart block risk with Non-DHPs), Digoxin.
7.  **Dosage & Administration:** Oral or IV. Monitor pulse/BP.
8.  **Patient Education:** Avoid grapefruit juice. Increase fiber/fluids (Verapamil). Check pulse.

#### D. Beta-Adrenergic Blockers
1.  **Drug Name:** Metoprolol (Lopressor), Atenolol (Tenormin), Propranolol (Inderal - Non-selective), Nadolol (Corgard), Carvedilol (Coreg - Alpha/Beta).
2.  **Class/Mechanism:** Blocks beta-1 (heart) and beta-2 (lungs/liver) receptors. Reduces HR, BP, and contractility.
3.  **Indications:** HTN, Angina, Heart Failure, Post-MI, Dysrhythmias, Anxiety.
4.  **Contraindications:** **Asthma/COPD (for non-selective)**, Bradycardia, Heart block.
5.  **Adverse Effects:** **Bradycardia**, **Bronchospasm**, Fatigue, Orthostatic hypotension. **Masks hypoglycemia symptoms** (masks tachycardia).
6.  **Drug Interactions:** CCBs (Verapamil/Diltiazem), Insulin (masks hypoglycemia), NSAIDs (reduce effect).
7.  **Dosage & Administration:** Oral/IV. **Check apical pulse/BP; hold if HR < 60.**
8.  **Patient Education:** **Do NOT stop abruptly** (rebound HTN/MI). Taper over 1-2 weeks. Diabetics check BG frequently.

#### E. Diuretics
*   **Loop (Furosemide - Lasix):**
    *   **Mechanism:** Blocks Na/K/Cl in Loop of Henle. Most potent.
    *   **Adverse:** **Ototoxicity** (tinnitus), Hypokalemia, Hypocalcemia, Dehydration.
*   **Thiazide (HCTZ):**
    *   **Mechanism:** Blocks Na/Cl in distal tubule.
    *   **Adverse:** **Hypokalemia**, **Hypercalcemia**, Hyperglycemia, Hyperuricemia (Gout).
*   **Potassium-Sparing (Spironolactone):**
    *   **Mechanism:** Aldosterone antagonist.
    *   **Adverse:** **Hyperkalemia**, Gynecomastia.
*   **Education for all:** Take in the **morning** (prevent nocturia). Monitor weight daily. Loop/Thiazide: Eat high K+ foods. K-Sparing: Avoid high K+ foods.

---

### 3. Angina and Heart Failure

#### A. Nitrates
1.  **Drug Name:** Nitroglycerin (Nitrostat), Isosorbide Dinitrate/Mononitrate.
2.  **Class/Mechanism:** Venous and coronary vasodilation; reduces preload/afterload.
3.  **Indications:** Acute angina (SL), chronic prophylaxis (patch/oral), HTN crisis (IV).
4.  **Contraindications:** Severe anemia, head injury, use of **Sildenafil (Viagra)** or other PDE5 inhibitors (fatal hypotension).
5.  **Adverse Effects:** **Headache** (very common), Hypotension, Reflex tachycardia.
6.  **Drug Interactions:** Alcohol, PDE5 inhibitors, other HTN meds.
7.  **Dosage & Administration:** SL (1 tab q 5min x 3 doses), Patch (apply to hairless area), IV.
8.  **Patient Education:** **Nitrate-free period (8-12 hrs)** to prevent tolerance (remove patch at night). SL: Stinging indicates freshness; do not swallow. If pain not relieved by 1st tab, call 911 then take 2nd.

#### B. Cardiac Glycosides: Digoxin (Lanoxin)
1.  **Drug Name:** Digoxin.
2.  **Class/Mechanism:** Positive Inotropic (stronger contraction), Negative Chronotropic (slower rate).
3.  **Indications:** Heart Failure, Atrial Fibrillation.
4.  **Contraindications:** Ventricular fibrillation, heart block.
5.  **Adverse Effects:** **Digoxin Toxicity** (levels > 2.4 ng/mL). Symptoms: **Yellow/Green halos**, blurred vision, N/V, bradycardia.
6.  **Drug Interactions:** **Diuretics (Hypokalemia increases toxicity risk)**, ACE-I/ARBs (Hyperkalemia reduces effect), Verapamil.
7.  **Dosage & Administration:** Oral/IV. **Apical pulse for 1 min; hold if < 60.** Therapeutic range: 0.8–2.0.
8.  **Patient Education:** Report vision changes or nausea. Check pulse at home. Antidote: Digibind.

---

### 4. Thromboembolic Disorders

#### A. Anticoagulants
*   **Heparin:** SQ/IV. Blocks thrombin. Monitor **aPTT** (1.5-2.5x normal). Risk of **HIT (Thrombocytopenia)**. Antidote: **Protamine Sulfate**.
*   **Enoxaparin (Lovenox):** LMW Heparin. SQ only. More predictable. No aPTT needed.
*   **Warfarin (Coumadin):** Oral. Inhibits Vitamin K factors. Monitor **PT/INR** (Target 2.0-3.0). **Antidote: Vitamin K**. Numerous drug/food interactions (Green leafy veg must be consistent).
*   **DOACs (Apixaban, Rivaroxaban, Dabigatran):** No routine labs. Fewer interactions.

#### B. Antiplatelets
*   **Aspirin:** Inhibits platelet aggregation. Used for PAD/CAD. Adverse: **Salicylism** (tinnitus), GI bleed. Avoid in children (Reye's).
*   **Clopidogrel (Plavix):** ADP inhibitor. Used for post-stent/stroke/MI. Watch for thrombocytopenia/bleeding.

---

## II. DIABETES MEDICATIONS

### 1. Insulins

| Type | Onset | Peak | Duration | Examples |
| :--- | :--- | :--- | :--- | :--- |
| **Rapid** | 15-30m | 0.5-2.5h | 3-6h | Lispro (Humalog), Aspart (Novolog) |
| **Short** | 30-60m | 1-5h | 6-10h | **Regular (Humulin R)** - **Only one for IV** |
| **Intermediate** | 1-2h | 6-14h | 16-24h | NPH (Humulin N) - Cloudy |
| **Long-Acting** | 70m | **None** | 24h | Glargine (Lantus), Detemir (Levemir) |

*   **Mechanism:** Promotes glucose uptake; converts glucose to glycogen.
*   **Mixing:** **Clear (Regular) before Cloudy (NPH)**.
*   **Administration:** SQ. Rotate sites (prevent **Lipohypertrophy**). Do not massage.
*   **Patient Education:** **Hypoglycemia signs** (shaky, sweaty, confused). 15/15 Rule: 15g carbs, wait 15 min.

### 2. Oral Antidiabetics

#### A. Biguanides: Metformin (Glucophage)
1.  **Mechanism:** Reduces liver glucose production; increases sensitivity.
2.  **Indication:** 1st line for Type 2 DM.
3.  **Adverse Effects:** GI upset (N/V/D), B12 deficiency, **Lactic Acidosis** (somnolence, hyperventilation).
4.  **Interactions:** **Iodine contrast media (Hold 48h before/after)**. Alcohol (Lactic acidosis risk).
5.  **Administration:** Take with food.

#### B. Sulfonylureas: Glipizide (Glucotrol), Glyburide
1.  **Mechanism:** Stimulates pancreas to release insulin.
2.  **Adverse Effects:** **Hypoglycemia**, Weight gain, Sulfa allergy risk.
3.  **Interactions:** **Alcohol (Disulfiram-like reaction)**, Beta-blockers (mask hypoglycemia).
4.  **Administration:** 30 min before meals.

#### C. SGLT2 Inhibitors: Canagliflozin (Invokana), Empagliflozin (Jardiance)
1.  **Mechanism:** Blocks glucose reabsorption in kidneys (sugar excreted in urine).
2.  **Adverse Effects:** **UTIs, Yeast infections**, polyuria, hypotension, DKA risk.
3.  **Nursing:** Beneficial for HF patients (Empagliflozin).

#### D. GLP-1 Agonists: Exenatide (Byetta), Liraglutide (Victoza), Semaglutide (Ozempic)
1.  **Mechanism:** Mimics incretin; slows gastric emptying; increases insulin release.
2.  **Adverse Effects:** **Pancreatitis** (severe abdominal pain), N/V, Weight loss.
3.  **Administration:** Injectable (Daily or Weekly).

#### E. Alpha-Glucosidase Inhibitors: Acarbose (Precose)
1.  **Mechanism:** Slows carb absorption in the intestine.
2.  **Adverse Effects:** **GI (gas, bloating, diarrhea)**, Anemia (decreased iron), Hepatotoxicity (long-term).
3.  **Administration:** Take with **first bite of food**.

#### F. TZDs: Pioglitazone (Actos)
1.  **Mechanism:** Increases tissue sensitivity to insulin.
2.  **Adverse Effects:** **Fluid retention**, weight gain, LDL elevation, hepatotoxicity, bone fractures.
3.  **Contraindication:** **Heart Failure**.
